Spis treści:
1. REPORT
2. INFORMATION ABOUT THE ENTITY
3. SIGNATURE OF PERSONS REPRESENTING THE COMPANY

Spis załączników:
  1. Detailed report on acquisition of treasury shares.pdfDetailed report on acquisition of treasury shares

POLISH FINANCIAL SUPERVISION AUTHORITY

UNI - EN REPORT No 47 / 2024
Date of issue: 2024-11-04
Short name of the issuer
KRKA
Subject
Acquisition of treasury shares
Official market - legal basis
Unofficial market - legal basis
Contents of the report:
Based on the provisions of the Rules of the Ljubljana Stock Exchange, d. d., Ljubljana and Article 2 of the Commission Delegated Regulation (EU) 2016/1052 Krka, d. d., Novo mesto announces:

With a reference to the public notice from 20 July 2023, Krka is publicly disclosing information on transactions relating to buy-back programme in the period from 25 October 2024 up to and including 30 October 2024. Krka acquired 3,525 treasury shares in the total value of EUR 479,224 on the Ljubljana Stock Exchange as follows:

- on 25 October 2024: 875 shares at a VWAP of EUR 135.67,
- on 28 October 2024: 872 shares at a VWAP of EUR 136.00,
- on 29 October 2024: 884 shares at a VWAP of EUR 136.00 and
- on 30 October 2024: 894 shares at a VWAP of EUR 136.13.

Price is calculated as volume weighted average price (VWAP).
Ilirika d.d., Intercapital d.d. and NLB d.d. were brokers in these transactions. Detailed report on acquisition of treasury shares attached.

The total number of treasury shares prior to these transactions was 2,064,753 representing 6.296% of all shares issued.
The total number of treasury shares after these transactions is 2,068,278 representing 6.307% of all shares issued.

The notice will be published on the Company's website (www.krka.biz) from 4 November 2024 onwards, for a period of at least 5 years.
Annexes
File Description
Detailed report on acquisition of treasury shares.pdf
Detailed report on acquisition of treasury shares.pdf		 Detailed report on acquisition of treasury shares

KRKA, TOVARNA ZDRAVIL D.D.
(fullname of the issuer)
KRKA Farmaceutyczny (far)
(short name of the issuer) (sector according to clasification
of the WSE in Warsow)
8501 Nove Mesto
(post code) (city)
Smarjeska 6
(street) (number)
+386 7 331 21 11 +386 7 332 15 37
(phone number) (fax)
(e-mail) (web site)
nie dotyczy
(NIP) (REGON)

SIGNATURE OF PERSONS REPRESENTING THE COMPANY
Date Name Position / Function Signature
2024-11-04 Jože Colarič President of the Management Board and CEO
20241104_104204_1020070781_Detailed_report_on_acquisition_of_treasury_shares.pdf

Pobierz